Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2014 | 1 Million USD | -34.94% |
| 2013 | 1.53 Million USD | 171.83% |
| 2012 | 565.68 Thousand USD | 14.04% |
| 2011 | 496.03 Thousand USD | -11.27% |
| 2010 | 559.04 Thousand USD | 8.81% |
| 2009 | 513.78 Thousand USD | -55.52% |
| 2008 | 1.15 Million USD | 365.86% |
| 2007 | 247.94 Thousand USD | -95.06% |
| 2006 | 5.01 Million USD | 1282.37% |
| 2005 | 363 Thousand USD | 44.62% |
| 2004 | 251 Thousand USD | -68.4% |
| 2003 | 794.4 Thousand USD | 83.53% |
| 2002 | 432.84 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2015 Q1 | 988.04 Thousand USD | -1.23% |
| 2015 Q3 | 1 Million USD | -3.84% |
| 2015 Q2 | 1.04 Million USD | 6.26% |
| 2014 Q3 | 1.1 Million USD | -10.09% |
| 2014 Q4 | 1 Million USD | -9.35% |
| 2014 FY | 1 Million USD | -34.94% |
| 2014 Q1 | 1.65 Million USD | 7.57% |
| 2014 Q2 | 1.22 Million USD | -25.8% |
| 2013 Q4 | 1.53 Million USD | 84.2% |
| 2013 Q3 | 834.79 Thousand USD | 39.47% |
| 2013 Q2 | 598.54 Thousand USD | 32.29% |
| 2013 Q1 | 452.44 Thousand USD | -20.02% |
| 2013 FY | 1.53 Million USD | 171.83% |
| 2012 FY | 565.68 Thousand USD | 14.04% |
| 2012 Q1 | 436.38 Thousand USD | -12.02% |
| 2012 Q3 | 602.08 Thousand USD | 0.0% |
| 2012 Q4 | 565.68 Thousand USD | -6.05% |
| 2011 Q2 | 494.42 Thousand USD | -3.3% |
| 2011 Q4 | 496.03 Thousand USD | -1.35% |
| 2011 Q3 | 502.81 Thousand USD | 1.7% |
| 2011 Q1 | 511.3 Thousand USD | -8.54% |
| 2011 FY | 496.03 Thousand USD | -11.27% |
| 2010 Q1 | 530.73 Thousand USD | 3.3% |
| 2010 FY | 559.04 Thousand USD | 8.81% |
| 2010 Q4 | 559.04 Thousand USD | 40.9% |
| 2010 Q3 | 396.77 Thousand USD | -6.28% |
| 2010 Q2 | 423.38 Thousand USD | -20.23% |
| 2009 Q1 | 806.74 Thousand USD | -30.16% |
| 2009 FY | 513.78 Thousand USD | -55.52% |
| 2009 Q2 | 958.77 Thousand USD | 18.84% |
| 2009 Q4 | 513.78 Thousand USD | 0.0% |
| 2008 Q2 | 1.07 Million USD | -69.66% |
| 2008 Q1 | 3.52 Million USD | 1322.69% |
| 2008 Q3 | 1.24 Million USD | 16.46% |
| 2008 Q4 | 1.15 Million USD | -7.35% |
| 2008 FY | 1.15 Million USD | 365.86% |
| 2007 Q4 | 247.94 Thousand USD | -74.42% |
| 2007 FY | 247.94 Thousand USD | -95.06% |
| 2007 Q1 | 4.97 Million USD | -0.95% |
| 2007 Q2 | 979.1 Thousand USD | -80.3% |
| 2007 Q3 | 969.13 Thousand USD | -1.02% |
| 2006 Q3 | 3.03 Million USD | 648.08% |
| 2006 FY | 5.01 Million USD | 1282.37% |
| 2006 Q1 | 336.65 Thousand USD | -7.26% |
| 2006 Q4 | 5.01 Million USD | 65.51% |
| 2006 Q2 | 405.27 Thousand USD | 20.38% |
| 2005 Q1 | 1.21 Million USD | 384.92% |
| 2005 FY | 363 Thousand USD | 44.62% |
| 2005 Q3 | 432.25 Thousand USD | -6.16% |
| 2005 Q4 | 363 Thousand USD | -16.02% |
| 2005 Q2 | 460.64 Thousand USD | -62.15% |
| 2004 Q3 | 769.02 Thousand USD | 12.53% |
| 2004 FY | 251 Thousand USD | -68.4% |
| 2004 Q2 | 683.37 Thousand USD | -9.58% |
| 2004 Q1 | 755.81 Thousand USD | -4.86% |
| 2004 Q4 | 251 Thousand USD | -67.36% |
| 2003 Q2 | 691.75 Thousand USD | 65.83% |
| 2003 Q4 | 794.4 Thousand USD | -10.35% |
| 2003 Q1 | 417.14 Thousand USD | -3.63% |
| 2003 Q3 | 886.15 Thousand USD | 28.1% |
| 2003 FY | 794.4 Thousand USD | 83.53% |
| 2002 Q3 | 1.04 Million USD | 0.0% |
| 2002 FY | 432.84 Thousand USD | 0.0% |
| 2002 Q4 | 432.84 Thousand USD | -58.4% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | 21.167% |
| Atlantic International Corp. | 4.43 Million USD | 77.45% |
| Biocept, Inc. | 30.87 Million USD | 96.76% |
| Bioqual, Inc. | 56.58 Million USD | 98.232% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -331.329% |
| DermTech, Inc. | 121.93 Million USD | 99.18% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.976% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 94.373% |
| iMD Companies, Inc. | 190.13 Thousand USD | -426.141% |
| IDenta Corp. | 1.52 Million USD | 34.584% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 92.317% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 87.877% |
| InVitro International | 1.53 Million USD | 34.786% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 96.272% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -43169.42% |
| Medical Imaging Corp. | 4.19 Million USD | 76.134% |
| NovelStem International Corp. | 2.25 Million USD | 55.628% |
| Optigenex Inc. | 1.88 Million USD | 47.021% |
| PharmChem, Inc. | 2.76 Million USD | 63.827% |
| Proteome Sciences plc | 14.58 Million USD | 93.141% |
| Response Genetics, Inc | 48.88 Million USD | 97.954% |
| Rennova Health, Inc. | 20.57 Million USD | 95.137% |
| RushNet, Inc. | 6.04 Million USD | 83.458% |
| ScreenPro Security Inc. | 1.26 Million USD | 20.69% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -111.757% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -42.78% |
| Todos Medical Ltd. | 15.26 Million USD | 93.447% |